Clinical features of hemophagocytic lymphohistiocytosis with abnormal liver function as the initial manifestation

Ceng QingHuan; Sun YaNan; Liu YuanZhi; Li Peng; Yu HaiBin; Wu YanJing; Xiong Feng; Zhang ShiBin

doi:10.3969/j.issn.1001-5256.2018.10.024

Issue 10

Oct. 2018

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2018 > 34(10): 2186-2189

PDF( 1817 KB)

Clinical features of hemophagocytic lymphohistiocytosis with abnormal liver function as the initial manifestation

DOI: 10.3969/j.issn.1001-5256.2018.10.024

Center of Hepatic and Digestive Diseases, Beijing YouAn Hospital, Capital Medical University

Published Date: 2018-10-20

Abstract

Abstract

Objective To investigate the clinical and laboratory features of hemophagocytic lymphohistiocytosis ( HLH) with abnormal liver function as the initial manifestation, and to increase the awareness of this disease. Methods A retrospective analysis was performed for the clinical data of 11 patients who attended the hospital due to abnormal liver function from November 2011 to October 2017 and were diagnosed with HLH, including their medical history, etiology, clinical manifestation, laboratory examination results, and prognosis. Results Of all11 patients, 9 ( 81. 8%) had infection as the etiology of HLH, and as for clinical manifestation, 11 ( 100%) had pyrexia and 9 ( 81. 8%) had splenomegaly. Laboratory examination showed varying degrees of abnormal liver function in all patients, among whom 10 ( 90. 9%) had elevated alanine aminotransferase, 11 ( 100%) had elevated aspartate aminotransferase, 10 ( 90. 9%) had an increase in total bilirubin, 9 ( 81. 8%) had a reduction in albumin, 10 ( 90. 9%) had a reduction in cholinesterase, 9 ( 81. 8%) had an increase in gamma-glutamyl transpeptidase, 10 ( 90. 9%) had an increase in alkaline phosphatase, and 5 ( 83. 3%) had an increase in lactate dehydrogenase. Elevated ferritin in the early course of the disease had the highest sensitivity ( 11/11, 100%) in the diagnosis of this disease, followed by triglyceride >3 mmol/L ( 6/7, 85. 7%) . In the early course of the disease, the positive rates of peripheral cytopenia of two or more lineages and reduced fibrinogen were 54. 5% and 45. 4%, respectively. Dynamic monitoring showed that all patients experienced peripheral cytopenia of two or more lineages. Hemophagocytosis was observed in all patients. NK cell activity and soluble CD25 ( s CD25) level were measured for 7 patients, and they all had a reduction in NK cell activity and an increase in s CD25 level. Conclusion Some diagnostic indices of HLH have a low positive rate in the early course of the disease. For patients with unexplained abnormal liver function and persistent fever, HLH cannot be excluded even if no significant peripheral cytopenia is observed in the early stage. The change in blood cells should be monitored, and laboratory examination including ferritin and blood lipids should be performed as early as possible to assist early diagnosis and treatment.
- lymphohistiocytosis, hemophagocytic,
- hepatic insufficiency,
- diagnosis

FullText(HTML)

References(13)

References

[1]JORDAN MB, ALIEN CE, WEITZMAN S, et al.How I treat hemophagocytic lymphohistiocytosis[J].Blood, 2011, 118 (15) :4041-4052.

[2]HENTER JI, HORNE A, ARICM, et al.HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer, 2007, 48 (2) :124-131.

[3]LIN RR, WANG Z.New advances in the pathogenesis, diagnosis, and treatment of primary hemophagocytic syndrome[J].J Clin Intern Med, 2011, 28 (5) :358-360. (in Chinese) 林榕榕, 王昭.原发性噬血细胞综合征发病机制及诊断治疗新进展[J].临床内科杂志, 2011, 28 (5) :358-360.

[4]KARRAS A.What nephrologists need to know about hemophagocytic syndrome[J].Nat Rev Nephrol, 2009, 5 (6) :329-336.

[5]YANG GQ, LIU WC, ZHANG B, et al.Brucella-related hemophagocytic syndrome:An analysis of 2 cases[J].Inter J Epidemiol Infect Dis, 2010, 37 (4) :285-286. (in Chinese) 杨桂强, 刘文超, 张斌, 等.布鲁杆菌相关性噬血细胞综合征二例[J].国际流行病学传染病学杂志, 2010, 37 (4) :285-286.

[6]GUO J, SUN M.Etiology of pediatric acute liver failure[J].J Clin Hepatol, 2017, 33 (10) :1931-1935. (in Chinese) 郭静, 孙梅.儿童急性肝衰竭的病因分析[J].临床肝胆病杂志, 2017, 33 (10) :1931-1935.

[7]XU JH, LU HY, YU YY.Chronic active EBV infection with histiocytic necrotizing lymphadenitis:A case report[J].J Clin Hepatol, 2017, 33 (10) :1994-1996. (in Chinese) 许俊辉, 陆海英, 于岩岩.慢性活动性EB病毒感染合并组织细胞增生性坏死性淋巴结炎1例报告[J].临床肝胆病杂志, 2017, 33 (10) :1994-1996.

[8]XIAO L, GUAN XM, MENG Y, et al.Analysis of clinical and laboratory features of 217 pediatric hemophagocytic lymphohistiocytosis[J].Chin J Hematol, 2014, 35 (7) :628-632. (in Chinese) 肖莉, 管贤敏, 孟岩, 等.217例噬血细胞性淋巴组织细胞增生症患儿的临床及实验室检查特点分析[J].中华血液学杂志, 2014, 35 (7) :628-632.

[9]WANG YN, WANG Z, WU L, et al.A multicenter retrospective analysis of diagnosis and treatment of 72 hemophagocytic syndrome patients[J].Chin J Hematol, 2009, 30 (12) :793-798. (in Chinese) 王旖旎, 王昭, 吴林, 等.多中心72例噬血细胞综合征诊疗分析[J].中华血液学杂志, 2009, 30 (12) :793-798.

[10]GUPTA A, WEITZMAN S, ABDELHALEEM M, et al.The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer, 2008, 50 (2) :192-194.

[11]WANG Z, WANG YN, FENG CC, et al.Diagnostic significance of NK cell activity and soluble CD25 level in serum from patients with secondary hemophagocytic lymphohistiocytosis[J].J Exp Hematol, 2008, 16 (5) :1154-1157. (in Chinese) 王昭, 王旖旎, 冯翠翠, 等.NK细胞活性和血清可溶性CD25在继发性噬血细胞性淋巴组织细胞增多症的诊断意义[J].中国实验血液学杂志, 2008, 16 (5) :1154-1157.

[12]DU XR, XU L, CAI J, et al.Clinical features and prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis[J].Chin J Clin Infect Dis, 2014, 7 (2) :111-115. (in Chinese) 杜兴冉, 徐喨, 蔡洁, 等.EB病毒相关噬血细胞性淋巴组织细胞增生症的临床特征及预后危险因素分析[J].中华临床感染病杂志, 2014, 7 (2) :111-115.

[13]FILIPOVICH AH.Hemophagocytic lymphohistiocytosis (HLH) and related disorders[J].Hematology Am Soc Hematol Educ Program, 2009, 2009 (1) :127-131.

Relative Articles

[1]	Tong LIU, Shanzheng LI, Cheng ZHOU, Sutong LIU, Lihui ZHANG, Wenxia ZHAO. Study on the protective efect and mechanism of paeoniflorin on palmitic acid-induced HepG2 cells[J]. Journal of Clinical Hepatology, 2025, 41(3): 499-505. doi: 10.12449/JCH250316
[2]	Lai Xin, Zhou TaiCheng, Wei Jia. Association between HBV A1762T/G1764A double nucleotide substitution and liver diseases[J]. Journal of Clinical Hepatology, 2018, 34(9): 1990-1994. doi: 10.3969/j.issn.1001-5256.2018.09.034
[3]	Pang Ting, Xing HuiChun. Correlation between drug-resistance gene mutations and hepatocellular carcinoma in patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2017, 33(1): 82-86. doi: 10.3969/j.issn.1001-5256.2017.01.017
[4]	Du SenRong, Mao XiaoRong, Xiao Ping, Chen Hong. Effects of PARP-1 inhibitors AG-014699 and AZD2281 on proliferation and apoptosis of human hepatoma cell line HepG2[J]. Journal of Clinical Hepatology, 2015, 31(6): 943-946. doi: 10.3969/j.issn.1001-5256.2015.06.027
[5]	Wang LiPing, Han FangZheng, Li ChunYang, Yan Mei, Zhang YanChao, Yan XueBing. Evaluation of adefovir primary resistance and adefovir repulsive mutations of the HBV DNA P gene in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(8): 606-608.
[6]	Jin WenWen, Xin YongNing, Dong QuanJiang, Zhao ShouFeng, Yu XinJuan, Jiang Man, Xu Jing, Xuan ShiYing. The preliminary study on the relationship between hepatitis B virus BCP gene mutations and HBV-related primary hepatocellular carcinoma in Qingdao[J]. Journal of Clinical Hepatology, 2012, 28(2): 130-134.
[7]	Yang YanLin, Xiao Ping, Gao Peng, Wang LiMing, Wei XiSheng, He Qiang, Zhou Ping. Distribution of HBV genotypes and YMDD mutations in E antigen-positive patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 428-430.
[8]	Hong YuBo, Zhang Ting, Sun LiGuang. Association between IL-2 +114 (G/T) polymorphism and susceptibility to hepatitis B, cirrhosis, and hepatocellular carcinoma in Jilin province[J]. Journal of Clinical Hepatology, 2012, 28(12): 930-933.
[9]	Deng Le, Wen ZhiLi. Review of recent research progress in correlating HBV genotypes with efficacy of antiviral treatments[J]. Journal of Clinical Hepatology, 2012, 28(6): 469-473.
[10]	Zhang JianJun, Wu LiPing, Du RuiQing, Wang JianBin, Yao ZhanCheng, Yu GuiQin. Factors correlating with the liver inflammation grade ≥G2 in chronic HBV-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2012, 28(1): 35-38.
[11]	Liu JinPing, Liu YouDe, Guo YanMei, Yang ShaoPing, Lin Qing, Lin Ling. Clinical characteristics and distribution of hepatitis B virus genotypes in CHB patients in Yantai area[J]. Journal of Clinical Hepatology, 2011, 27(12): 1288-1290.
[12]	Zou XiaoJing, Jiang XueQiang, Tian DeYing. Role of DC-SIGN on the maturation and activation of dendritic cells in chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 145-147+153.
[13]	Xiong QiXiang, Xiong LiJuan. Hepatitis B virus infection and DNA methylation in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(8): 881-884.
[14]	Pan Lei, Wei Xin, Xie YuMei, Hao ChunQiu, Wang JiuPing, Jia ZhanSheng, Bai XueFan. Anti-viral therapy with pegylated interferon alpha-2a plus ribavirin in patients co-infected with HBV and HCV[J]. Journal of Clinical Hepatology, 2011, 27(1): 84-85+95.
[15]	Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165.
[16]	Xi HongLi, Liu FangFang, Yuan JiaYing, Yu YanYan. Significance and detection of IL-2、IL-4 and IFN-γ in PBMC from patients with hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(6): 627-629.
[17]	Wang GuoQiang, Niu JuXia. The HBx protein mutation among different HBV genotypes[J]. Journal of Clinical Hepatology, 2010, 26(4): 392-394.
[18]	Shi YanMei, Lan YingHua, Dan Lei, Zhou Jin, Li YongGuo. The relationship between of hematopoietic stem cells and hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2010, 26(4): 377-380.
[19]	Xie DeSheng, Zhang QingBo, Chen ChangXing, Huang JianFang, Ma Jin, Huang HaiBin, Du Yao. The relationship between HBV gene mutation in HBV infected family and HLA class Ⅱ alleles[J]. Journal of Clinical Hepatology, 2010, 26(4): 383-386.
[20]	Xu ZhengJu, Yang Hong, Zhang QiHua, Chen XianLi, Li ShuQing, Wang ChongGuo. Study on the relationship between hepatitis B virus genotypes and effect of lamivudine therapy.[J]. Journal of Clinical Hepatology, 2005, 21(3): 157-159.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	中国抗癌协会肿瘤消融治疗专业委员会，中国临床肿瘤学会肿瘤消融治疗专家委员会，中国医师协会介入医师分会介入围手术学组. 复合式冷热消融治疗肝肿瘤围手术期管理专家共识. 中华内科杂志. 2025(02): 110-118 .
2.	温钊，臧铁柱，宋晓改，张炫，江艳丽. 射频消融治疗包膜下与非包膜下早期肝细胞癌患者的远期预后. 河南医学研究. 2023(15): 2738-2744 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2267) PDF downloads(344)

Clinical features of hemophagocytic lymphohistiocytosis with abnormal liver function as the initial manifestation

DOI: 10.3969/j.issn.1001-5256.2018.10.024